Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment
Q Gao, J Feng, W Liu, C Wen, Y Wu, Q Liao… - Advanced drug delivery …, 2022 - Elsevier
The therapeutic limitations such as insufficient efficacy, drug resistance, metastasis, and
undesirable side effects are frequently caused by the long duration monotherapy based on …
undesirable side effects are frequently caused by the long duration monotherapy based on …
[HTML][HTML] Natural products as chemo-radiation therapy sensitizers in cancers
Cancer is a devastating disease and is the second leading cause of death worldwide.
Surgery, chemotherapy (CT), and/or radiation therapy (RT) are the treatment of choice for …
Surgery, chemotherapy (CT), and/or radiation therapy (RT) are the treatment of choice for …
Role of plant-derived active constituents in cancer treatment and their mechanisms of action
Despite significant technological advancements in conventional therapies, cancer remains
one of the main causes of death worldwide. Although substantial progress has been made …
one of the main causes of death worldwide. Although substantial progress has been made …
[HTML][HTML] Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance
J Gong, T Shi, J Liu, Z Pei, J Liu, X Ren, F Li… - Biomedicine & …, 2023 - Elsevier
Multidrug resistance (MDR) promotes tumor recurrence and metastasis and heavily reduces
anticancer efficiency, which has become a primary reason for the failure of clinical …
anticancer efficiency, which has become a primary reason for the failure of clinical …
Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism
J Wei, Z Liu, J He, Q Liu, Y Lu, S He, B Yuan… - Clinical and …, 2022 - Springer
Chemotherapy is one of the most commonly used clinical treatments among the currently
available cancer therapies. However, the phenomenon of Multidrug resistance (MDR) has …
available cancer therapies. However, the phenomenon of Multidrug resistance (MDR) has …
Lactoferrin-modified gambogic acid liposomes for colorectal cancer treatment
R Wang, J Qu, X Tang, J Zhang, A Ou, Q Li… - Molecular …, 2023 - ACS Publications
Colorectal cancer (CRC) therapy is a big challenge, and seeking an effective and safe drug
is a pressing clinical need. Gambogic acid is a potent antineoplastic agent without the …
is a pressing clinical need. Gambogic acid is a potent antineoplastic agent without the …
HDAC inhibitory and anti-cancer activities of curcumin and curcumin derivative CU17 against human lung cancer A549 cells
N Namwan, G Senawong, C Phaosiri, P Kumboonma… - Molecules, 2022 - mdpi.com
Previous research reported that the curcumin derivative (CU17) inhibited several cancer cell
growths in vitro. However, its anticancer potential against human lung cancer cells (A549 …
growths in vitro. However, its anticancer potential against human lung cancer cells (A549 …
[HTML][HTML] Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
Z Wang, L Yang - Pharmacological Research, 2024 - Elsevier
Cancer, with its diversity, heterogeneity, and complexity, is a significant contributor to global
morbidity, disability, and mortality, highlighting the necessity for transformative treatment …
morbidity, disability, and mortality, highlighting the necessity for transformative treatment …
Application of natural products in regulating ferroptosis in human diseases
L Deng, W Tian, L Luo - Phytomedicine, 2024 - Elsevier
Background Ferroptosis is a type of cell death caused by excessive iron-induced
peroxidation. It has been found to be involved in a variety of diseases, and natural products …
peroxidation. It has been found to be involved in a variety of diseases, and natural products …
Recent trends and advances in novel formulations as an armament in Bcl-2/Bax targeted breast cancer
Breast cancer (BC) remains a significant health burden worldwide, necessitating the
development of innovative therapeutic strategies. The B-cell lymphoma 2 (Bcl-2) family …
development of innovative therapeutic strategies. The B-cell lymphoma 2 (Bcl-2) family …